Investigational New Drug
Concept
An exemption from selling an unapproved drug, required by the FDA for companies to conduct clinical trials on new drug formulations. This is a crucial step in the drug approval pathway.
Mentioned in 1 video
An exemption from selling an unapproved drug, required by the FDA for companies to conduct clinical trials on new drug formulations. This is a crucial step in the drug approval pathway.